274 related articles for article (PubMed ID: 23388639)
1. Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes.
Pang WW; Pluvinage JV; Price EA; Sridhar K; Arber DA; Greenberg PL; Schrier SL; Park CY; Weissman IL
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):3011-6. PubMed ID: 23388639
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis of myelodysplastic syndromes by excessive mitochondrial fragmentation].
Hayashi Y
Rinsho Ketsueki; 2024; 65(4):249-254. PubMed ID: 38684435
[TBL] [Abstract][Full Text] [Related]
3. Single-cell transcriptomics dissects the transcriptome alterations of hematopoietic stem cells in myelodysplastic neoplasms.
Zeng X; Wang Y; Dai M; Li W; Huang Q; Qin L; Li Y; Yan Y; Xue X; Yi F; Li W; He L; Liu Q; Qi L
J Transl Med; 2024 Apr; 22(1):359. PubMed ID: 38632656
[TBL] [Abstract][Full Text] [Related]
4. PI3-kinase deletion promotes myelodysplasia by dysregulating autophagy in hematopoietic stem cells.
Ames K; Kaur I; Shi Y; Tong MM; Sinclair T; Hemmati S; Glushakow-Smith SG; Tein E; Gurska L; Steidl U; Dubin R; Shan J; Montagna C; Pradhan K; Verma A; Gritsman K
Sci Adv; 2023 Feb; 9(8):eade8222. PubMed ID: 36812307
[TBL] [Abstract][Full Text] [Related]
5. Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasms.
Dussiau C; Comont T; Knosp C; Vergnolle I; Bravetti C; Canali A; Houvert A; Largeaud L; Daveaux C; Zaroili L; Friedrich C; Boussaid I; Zalmai L; Almire C; Rauzy O; Willems L; Birsen R; Bouscary D; Fontenay M; Kosmider O; Chapuis N; Vergez F
Leukemia; 2024 May; 38(5):1131-1142. PubMed ID: 38575672
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the Link between Class 1A PI3-Kinase, Autophagy, and Myelodysplasia.
Ames K; Gritsman K
Autophagy; 2024 Apr; 20(4):952-954. PubMed ID: 37289024
[TBL] [Abstract][Full Text] [Related]
7. Why Single-Cell Sequencing Has Promise in MDS.
Zhang X; Grimes HL
Front Oncol; 2021; 11():769753. PubMed ID: 34926276
[TBL] [Abstract][Full Text] [Related]
8. Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk.
Feng M; Chen JY; Weissman-Tsukamoto R; Volkmer JP; Ho PY; McKenna KM; Cheshier S; Zhang M; Guo N; Gip P; Mitra SS; Weissman IL
Proc Natl Acad Sci U S A; 2015 Feb; 112(7):2145-50. PubMed ID: 25646432
[TBL] [Abstract][Full Text] [Related]
9. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission.
Corces-Zimmerman MR; Hong WJ; Weissman IL; Medeiros BC; Majeti R
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2548-53. PubMed ID: 24550281
[TBL] [Abstract][Full Text] [Related]
10. Clonal origins of the hematopoietic system: the single most elegant experiment.
Weissman IL
J Immunol; 2014 Jun; 192(11):4943-4. PubMed ID: 24837150
[No Abstract] [Full Text] [Related]
11. Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response.
Tseng D; Volkmer JP; Willingham SB; Contreras-Trujillo H; Fathman JW; Fernhoff NB; Seita J; Inlay MA; Weiskopf K; Miyanishi M; Weissman IL
Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11103-8. PubMed ID: 23690610
[TBL] [Abstract][Full Text] [Related]
12. Stem and progenitor cell alterations in myelodysplastic syndromes.
Shastri A; Will B; Steidl U; Verma A
Blood; 2017 Mar; 129(12):1586-1594. PubMed ID: 28159737
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation.
Reinisch A; Etchart N; Thomas D; Hofmann NA; Fruehwirth M; Sinha S; Chan CK; Senarath-Yapa K; Seo EY; Wearda T; Hartwig UF; Beham-Schmid C; Trajanoski S; Lin Q; Wagner W; Dullin C; Alves F; Andreeff M; Weissman IL; Longaker MT; Schallmoser K; Majeti R; Strunk D
Blood; 2015 Jan; 125(2):249-60. PubMed ID: 25406351
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.
Woll PS; Kjällquist U; Chowdhury O; Doolittle H; Wedge DC; Thongjuea S; Erlandsson R; Ngara M; Anderson K; Deng Q; Mead AJ; Stenson L; Giustacchini A; Duarte S; Giannoulatou E; Taylor S; Karimi M; Scharenberg C; Mortera-Blanco T; Macaulay IC; Clark SA; Dybedal I; Josefsen D; Fenaux P; Hokland P; Holm MS; Cazzola M; Malcovati L; Tauro S; Bowen D; Boultwood J; Pellagatti A; Pimanda JE; Unnikrishnan A; Vyas P; Göhring G; Schlegelberger B; Tobiasson M; Kvalheim G; Constantinescu SN; Nerlov C; Nilsson L; Campbell PJ; Sandberg R; Papaemmanuil E; Hellström-Lindberg E; Linnarsson S; Jacobsen SE
Cancer Cell; 2014 Jun; 25(6):794-808. PubMed ID: 24835589
[TBL] [Abstract][Full Text] [Related]
15. Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes.
Gañán-Gómez I; Wei Y; Starczynowski DT; Colla S; Yang H; Cabrero-Calvo M; Bohannan ZS; Verma A; Steidl U; Garcia-Manero G
Leukemia; 2015 Jul; 29(7):1458-69. PubMed ID: 25761935
[TBL] [Abstract][Full Text] [Related]
16. Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis.
Zhao JL; Ma C; O'Connell RM; Mehta A; DiLoreto R; Heath JR; Baltimore D
Cell Stem Cell; 2014 Apr; 14(4):445-459. PubMed ID: 24561084
[TBL] [Abstract][Full Text] [Related]
17. High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias.
Shin JY; Hu W; Naramura M; Park CY
J Exp Med; 2014 Feb; 211(2):217-31. PubMed ID: 24446491
[TBL] [Abstract][Full Text] [Related]
18. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.
Gordon SR; Maute RL; Dulken BW; Hutter G; George BM; McCracken MN; Gupta R; Tsai JM; Sinha R; Corey D; Ring AM; Connolly AJ; Weissman IL
Nature; 2017 May; 545(7655):495-499. PubMed ID: 28514441
[TBL] [Abstract][Full Text] [Related]
19. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.
Shlush LI; Zandi S; Mitchell A; Chen WC; Brandwein JM; Gupta V; Kennedy JA; Schimmer AD; Schuh AC; Yee KW; McLeod JL; Doedens M; Medeiros JJ; Marke R; Kim HJ; Lee K; McPherson JD; Hudson TJ; ; Brown AM; Yousif F; Trinh QM; Stein LD; Minden MD; Wang JC; Dick JE
Nature; 2014 Feb; 506(7488):328-33. PubMed ID: 24522528
[TBL] [Abstract][Full Text] [Related]
20. Macrophages are critical effectors of antibody therapies for cancer.
Weiskopf K; Weissman IL
MAbs; 2015; 7(2):303-10. PubMed ID: 25667985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
